146 related articles for article (PubMed ID: 32469990)
1. The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
Grande SW; Adams LV; Maseko TSB; Talbot EA; deGijsel D; Mikal J; Simelane ZZ; Achili A; Mkhontfo M; Haumba SM
PLoS One; 2020; 15(5):e0232841. PubMed ID: 32469990
[TBL] [Abstract][Full Text] [Related]
2. High completion rates of isoniazid preventive therapy among persons living with HIV in Swaziland.
Adams LV; Mahlalela N; Talbot EA; Pasipamire M; Ginindza S; Calnan M; Haumba S
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1127-1132. PubMed ID: 28911356
[TBL] [Abstract][Full Text] [Related]
3. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
[TBL] [Abstract][Full Text] [Related]
4. "It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.
Jacobson KB; Niccolai L; Mtungwa N; Moll AP; Shenoi SV
AIDS Care; 2017 Jul; 29(7):936-942. PubMed ID: 28147705
[TBL] [Abstract][Full Text] [Related]
5. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
[TBL] [Abstract][Full Text] [Related]
7. Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.
Mueller Y; Mpala Q; Kerschberger B; Rusch B; Mchunu G; Mazibuko S; Bonnet M
Medicine (Baltimore); 2017 Sep; 96(35):e7740. PubMed ID: 28858089
[TBL] [Abstract][Full Text] [Related]
8. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia.
Zaeh S; Kempker R; Stenehjem E; Blumberg HM; Temesgen O; Ofotokun I; Tenna A
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1396-401. PubMed ID: 24125440
[TBL] [Abstract][Full Text] [Related]
9. Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.
Akamike IC; Okedo-Alex IN; Agu AP; Alo C; Ogbonnaya LU
Pan Afr Med J; 2020; 36():261. PubMed ID: 33014257
[TBL] [Abstract][Full Text] [Related]
10. Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
Huerga H; Mueller Y; Ferlazzo G; Mpala Q; Bevilacqua P; Vasquez B; Noël Mekiedje C; Ouattara A; Mchunu G; Weyenga HO; Varaine F; Bonnet M
J Acquir Immune Defic Syndr; 2016 Apr; 71(4):e89-95. PubMed ID: 26910386
[TBL] [Abstract][Full Text] [Related]
11. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
[No Abstract] [Full Text] [Related]
12. Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia.
Mindachew M; Deribew A; Tessema F; Biadgilign S
BMC Public Health; 2011 Dec; 11():916. PubMed ID: 22151609
[TBL] [Abstract][Full Text] [Related]
13. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews.
Adams LV; Talbot EA; Odato K; Blunt H; Steingart KR
BMC Infect Dis; 2014 May; 14():281. PubMed ID: 24886159
[TBL] [Abstract][Full Text] [Related]
14. Integrated and patient-selected care facilitates completion of isoniazid preventive therapy in Eswatini.
Adams LV; Maseko TSB; Talbot EA; Grande SW; Mkhontfo MM; Simelane ZZ; Achilla AA; Haumba SM
Public Health Action; 2019 Dec; 9(4):153-158. PubMed ID: 32042607
[TBL] [Abstract][Full Text] [Related]
15. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
[TBL] [Abstract][Full Text] [Related]
16. Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi.
Thindwa D; MacPherson P; Choko AT; Khundi M; Sambakunsi R; Ngwira LG; Kalua T; Webb EL; Corbett EL
Int J Tuberc Lung Dis; 2018 Mar; 22(3):273-279. PubMed ID: 29471904
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
18. Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study.
Dhungana GP; Thekkur P; Chinnakali P; Bhatta U; Pandey B; Zhang WH
BMJ Open; 2019 May; 9(5):e029058. PubMed ID: 31147370
[TBL] [Abstract][Full Text] [Related]
19. Adherence to Isoniazid Preventive Therapy among children living with tuberculosis patients in Delhi, India: An exploratory prospective study.
Sharma N; Basu S; Khanna A; Sharma P; Chopra KK; Chandra S
Indian J Tuberc; 2022 Jan; 69(1):100-103. PubMed ID: 35074140
[TBL] [Abstract][Full Text] [Related]
20. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.
Munseri PJ; Talbot EA; Mtei L; Fordham von Reyn C
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1037-41. PubMed ID: 18713501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
